Trajan Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31M Buy
33,121
+12,289
+59% +$3.4M 0.28% 87
2026
Q1
$6.15M Buy
20,832
+942
+5% +$280K 0.25% 75
2025
Q4
$5.43M Buy
19,890
+220
+1% +$59.8K 0.23% 74
2025
Q3
$5.31M Sell
19,670
-1
-0% -$272 0.23% 74
2025
Q2
$5.42M Sell
19,671
-45
-0.2% -$12.2K 0.27% 69
2025
Q1
$5.23M Buy
19,716
+519
+3% +$128K 0.29% 69
2024
Q4
$4.46M Buy
19,197
+407
+2% +$93.6K 0.25% 86
2024
Q3
$4.15M Buy
18,790
+1,905
+11% +$394K 0.24% 89
2024
Q2
$3.32M Buy
16,885
+250
+2% +$51.7K 0.21% 93
2024
Q1
$3.58M Buy
+16,635
New +$3.49M 0.24% 92

Other funds holding CME

Trajan Wealth's CME Position: Q2 2026 in Review

Trajan Wealth increased its CME Group (CME) stake by 59% in Q2 2026, buying an estimated $3.4M and bringing the position to 33,121 shares worth $7.31M. The position accounts for 0.28% of the portfolio, ranked #87.

Trajan Wealth first reported a position in CME in Q1 2024 and has held it in 10 quarters since. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Trajan Wealth held 33,121 shares of CME Group worth $7.31M as of Q2 2026.
  • Trajan Wealth bought 12,289 CME Group shares in Q2 2026, an estimated $3.4M.
  • CME Group made up 0.28% of Trajan Wealth's portfolio in Q2 2026, its #87 holding.
  • Trajan Wealth first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Trajan Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.